Exact Sciences

Madison, Wisconsin, United States ·Founded 1995

Overview

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.\\For more information on Exact Sciences'​ noninvasive colon cancer screening test, visit CologuardTest.com

Get the full list of 54,000+ investors

Exact Sciences and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Exact Sciences

Who are the partners at Exact Sciences?

Team members listed for Exact Sciences include Nicole Maassen (Senior Vice President - Market Access) and Stephen Noga (Medical Director, MRD).

How do I contact Exact Sciences?

Exact Sciences's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database